Glutamate buildup may drive mental fatigue, study finds
Researchers in Munich report that rising glutamate in the brain can explain why people avoid effortful tasks after heavy mental work.
Why does a long day of hard thinking leave people drained? New research suggests a chemical messenger called glutamate may be part of the answer, according to a Scientific American report published on November 4, 2026.
The leading idea
The study was led by Hongmei Xia, a Ph.D. student in cognitive neuroscience at Ludwig Maximilian University of Munich in Germany, together with colleagues. Xia said she was motivated by her own experience of feeling drained after long research days.
The team identified glutamate, a common neurotransmitter, as a likely cause. It builds up in parts of the brain during demanding mental tasks, and that buildup appears to reduce motivation to keep going even when persevering would bring a large reward.
Building on earlier work
A 2022 study by a team in Paris, led by Mathias Pessiglione of the Paris Brain Institute, found that sustained mental effort increased glutamate in the lateral prefrontal cortex, a region tied to cognitive control. The new work tested whether the link is causal.
How the experiment worked
Researchers used electrodes to stimulate the dorsolateral prefrontal cortex while participants tried to remember letters flashed on a screen. The stimulation improved performance on the task. Afterward, the stimulated participants were less willing to take on other cognitively demanding tasks than participants who were not stimulated, which indicated higher mental fatigue.
An analysis then showed that rising glutamate levels could account for that fatigue. The results appeared in the Proceedings of the National Academy of Sciences.
What experts say
Clay Holroyd of Ghent University in Belgium, who was not involved in the work, called it a causal study and “a very nice piece to this overall puzzle.”
Xia suggested that the unpleasant sensation of fatigue may be a “safety signal to tell you, ‘Okay, you should take a break.’” She noted that high glutamate concentrations can damage brain cells, and the brain may struggle to clear them during constant full-effort activity.
Some psychologists take a different view, arguing that fatigue signals that we are focused on a low-value task rather than more rewarding activities, prompting us to redirect effort. Pessiglione said the new study rules out a purely psychological explanation, since biological changes alone can induce fatigue. He suspects motivations and beliefs also matter, and said “A comprehensive account should articulate the two levels,” meaning the neurobiological and the psychological.
What comes next
Glutamate may not be the only factor. Holroyd’s lab is studying glutamate alongside lactate, a key brain energy source, as well as the anterior cingulate cortex, which is involved in attention and decision-making.
Xia hopes the findings could eventually lead to treatments for people especially prone to mental fatigue, such as those with depression or schizophrenia. Her practical advice for now is to switch to easier tasks and allow time for recovery: “Give some time to your brain.”
Sources
Written with automated tools from the sources above and published without editor review. Spotted an error? Tell us · Corrections Policy
Related stories
WHO warns drug resistance is outpacing global targets
WHO officials said on 16 November that progress against antimicrobial resistance is too slow, with a warning of up to 39 million deaths over 25 years, according to Al Jazeera.
WHO survey: climate-health plans rise, action still lags
A WHO survey of 146 countries finds over 90% now have climate and health focal points and more than half have plans, but financing, workforce and monitoring gaps are holding back implementation. The report lands as COP31 continues in Türkiye.
Daily GLP-1 pills raise hopes of closing diabetes care gap
Once-daily GLP-1 tablets could be cheaper and easier to store than injections, Al Jazeera reports. WHO backs the drugs conditionally but projects they will reach fewer than 10% of those who could benefit by 2030.
WHO issues new type 1 diabetes guidelines for World Diabetes Day
WHO has published new guidelines on insulin use in adults and its first on type 1 diabetes in children, both aimed at low-resource settings. A separate report asks whether daily pills could widen access to newer drugs.
